Pacira director files Form 3, reports no holdings

Pacira BioSciences, Inc. director Samit Hirawat filed an initial ownership report on Form 3.

Rhea-AI Filing Summary

Pacira BioSciences, Inc. director Samit Hirawat filed an initial ownership report on Form 3. The filing states that, as of the event date of 01/27/2026, no securities of Pacira BioSciences are beneficially owned. This is an administrative disclosure of current holdings status.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Pacira BioSciences (PCRX) director Samit Hirawat report on this Form 3?

The Form 3 reports that director Samit Hirawat currently has no beneficial ownership of Pacira BioSciences securities. This establishes a formal baseline of his holdings status under Section 16(a) reporting requirements as of the stated event date.

What is the event date disclosed in the Pacira BioSciences (PCRX) Form 3?

The Form 3 lists 01/27/2026 as the date of the event requiring the ownership statement. This date is used to define when the reported holdings status, including the absence of beneficially owned securities, is measured for SEC reporting purposes.

What position does the reporting person hold at Pacira BioSciences (PCRX)?

The reporting person, Samit Hirawat, is identified as a director of Pacira BioSciences, Inc. The form indicates he is not an officer or 10% owner, and the ownership disclosure is made solely in his capacity as a board member.

Does the Pacira BioSciences (PCRX) Form 3 show any securities beneficially owned?

No. The Form 3 expressly states in the remarks that no securities are beneficially owned. This means, as of the event date, the director reports no direct or indirect ownership of Pacira BioSciences equity securities requiring disclosure.

Is this Pacira BioSciences (PCRX) Form 3 filed by more than one reporting person?

No. The filing indicates it is a Form filed by one reporting person. Only director Samit Hirawat is listed as the reporting person, and there are no joint or group filers associated with this ownership report.

Are there any derivative securities disclosed for Pacira BioSciences (PCRX) in this Form 3?

No derivative securities are listed. Table II, which would show options or other derivatives, contains no entries, and the remarks confirm that no securities are beneficially owned by the reporting person at this time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/29/2026 - 04:50 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hirawat Samit

(Last) (First) (Middle)

C/O PACIRA BIOSCIENCES, INC.

2000 SIERRA POINT PARKWAY, SUITE 900

(Street)

BRISBANE CA 94005

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/27/2026

3. Issuer Name and Ticker or Trading Symbol
Pacira BioSciences, Inc. [ PCRX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

	/s/ Kristen Williams, Attorney-in-Fact	01/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.